Shanghai Allist Pharmaceuticals Co., Ltd.
688578
Rank in Stocks
#3127
Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese... Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese enterprise dedicated to the innovation and development of medicinal products. Headquartered in Shanghai, the company focuses its efforts on creating therapeutic agents specifically for the treatment of various tumor and cancer-related conditions.
Share Price
$12.65
Market Cap
$5.69B
Change (1 day)
-0.05%
Change (1 year)
-14.35%
Country
CN
Trade Shanghai Allist Pharmaceuticals Co., Ltd. (688578)
Category
Healthcare
Revenue for Shanghai Allist Pharmaceuticals Co., Ltd. (688578)
Revenue in Oct 2026 TTM: 0
According to Shanghai Allist Pharmaceuticals Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Shanghai Allist Pharmaceuticals Co., Ltd. from 2017 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2025 | $741.43M | 52.10% |
| 2024 | $487.45M | 70.97% |
| 2023 | $285.11M | 148.63% |
| 2022 | $114.67M | 37.49% |
| 2021 | $83.40M | 97,038.82% |
| 2020 | $85.86K | -5.06% |
| 2019 | $90.43K | -86.54% |
| 2018 | $671.64K | -43.45% |
| 2017 | $1.19M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $12.62B | - |
US
|
|
| $2.23B | - |
US
|
|
| $15.74B | - |
AU
|
|
| $10.11B | - |
BE
|
|
| $6.02B | - |
NL
|
